Solar Solutions Provider & CIMSME Launch User-Friendly Mobile App, Accelerating 1 Lakh Solar Home Target by 2026
Solar Solutions Provider & CIMSME Launch User-Friendly Mobile App, Accelerating 1 Lakh Solar Home Target by 2026

Solar Solutions Provider & CIMSME Launch User-Friendly Mobile App, Accelerating 1 Lakh Solar Home Target by 2026

The stock is up over 58 per cent from its 52-week low of Rs 73.50 per share and delivered multibagger returns of over 8,600 per cent in 5 years.

Kiran Shroff Article rating: 5.0

The stock is up over 58 per cent from its 52-week low of Rs 73.50 per share and delivered multibagger returns of over 8,600 per cent in 5 years.

Bloodbath on Dalal Street: Sensex & Nifty 50 Plunge, Broader Indices Suffer Steep Losses
Bloodbath on Dalal Street: Sensex & Nifty 50 Plunge, Broader Indices Suffer Steep Losses

Bloodbath on Dalal Street: Sensex & Nifty 50 Plunge, Broader Indices Suffer Steep Losses

The Nifty 50 has plummeted by 1.17 per cent to 22,281.65, and the Sensex has fallen by 1.27 per cent to 73,665.90.

Manoj Reddy Sama Article rating: 5.0

Market breadth is extremely negative, with 211 advances and 2,199 declines, indicating a severe negative sentiment prevailing among investors.

February 28: Key Market Updates Before Opening Bell
February 28: Key Market Updates Before Opening Bell

February 28: Key Market Updates Before Opening Bell

The GIFT Nifty hovered around 22,532 early in the morning, signaling a flat-to-muted opening for domestic equities.

Manoj Reddy Sama Article rating: 5.0

The S&P 500 slid 1.59 per cent to finish at 5,861.57, while the Nasdaq took a steep 2.78 per cent hit, closing at 18,544.42.

FIIs Favourite: Caplin Steriles Secures US FDA Approval, FIIs Stake Rises to 4.86 per cent
FIIs Favourite: Caplin Steriles Secures US FDA Approval, FIIs Stake Rises to 4.86 per cent

FIIs Favourite: Caplin Steriles Secures US FDA Approval, FIIs Stake Rises to 4.86 per cent

Caplin Point Laboratories has demonstrated robust financial performance in recent quarters. The company reported revenue of Rs 1,523 crore for Q3 FY25, which is equivalent to its full-year revenue in FY23.

Abhishek Wani Article rating: 4.7

Caplin Point Laboratories has demonstrated robust financial performance in recent quarters. The company reported revenue of Rs 1,523 crore for Q3 FY25, which is equivalent to its full-year revenue in FY23.

Sensex & Nifty End Flat, Midcap & Smallcap Indices Down Upto 1.7 Per Cent
Sensex & Nifty End Flat, Midcap & Smallcap Indices Down Upto 1.7 Per Cent

Sensex & Nifty End Flat, Midcap & Smallcap Indices Down Upto 1.7 Per Cent

The Nifty 50 ended marginally lower by 0.01 per cent at 22,545.05, and the Sensex inched up by 0.01 per cent to close at 74,612.43.

Manoj Reddy Sama Article rating: 1.0

Market breadth was heavily negative, with 571 advances and 2,292 declines, indicating a strong negative sentiment prevailed among investors.

Shares of this NBFC Soared by 19 per cent After RBI Notification; Earlier the this Micro Finance Organisation Secured USD 50 Million IFC Investment
Shares of this NBFC Soared by 19 per cent After RBI Notification; Earlier the this Micro Finance Organisation Secured USD 50 Million IFC Investment

Shares of this NBFC Soared by 19 per cent After RBI Notification; Earlier the this Micro Finance Organisation Secured USD 50 Million IFC Investment

With a market capitalisation of Rs 15,623 crore and a PE ratio of 17.7x, the company trades at a premium compared to the industry PE of 20.1x.

Prajwal Wakhare Article rating: 5.0
RSS
First1920212224262728Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR